Literature DB >> 7355762

Dose requirements of hydralazine in patients with severe chronic congestive heart failure.

M Packer, J Meller, N Medina, R Gorlin, M V Herman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7355762     DOI： 10.1016/s0002-9149(80)80019-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  14 in total

Review 1.  Effects of cardiovascular disease on pharmacokinetics.

Authors:  V Rodighiero
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

Review 2.  Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classification.

Authors:  M Packer
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics in heart failure. An updated review.

Authors:  F V Shammas; K Dickstein
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of hydralazine.

Authors:  T M Ludden; J L McNay; A M Shepherd; M S Lin
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

5.  Efficacy of felodipine in chronic congestive heart failure: a placebo controlled haemodynamic study at rest and during exercise and orthostatic stress.

Authors:  E Kassis; O Amtorp; S Waldorff; P Fritz-Hansen
Journal:  Br Heart J       Date:  1987-11

Review 6.  The treatment of heart failure. A methodological review of the literature.

Authors:  G H Guyatt
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

7.  Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.

Authors:  P M Schofield; N H Brooks; G P Lawrence; H J Testa; C Ward
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

8.  Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure.

Authors:  H Drexler; H Löllgen; H Just
Journal:  Klin Wochenschr       Date:  1981-06-15

Review 9.  The role of vasodilator therapy in the treatment of severe chronic heart failure.

Authors:  M Packer
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 10.  Vasodilators. A re-evaluation of their role in heart failure.

Authors:  L W Stevenson; G Fonarow
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.